Diabetes Research and Clinical Practice
Volume 50, Issue 2 , Pages 153-159 , 1 October 2000

Reduced pulmonary function and its associations in type 2 diabetes: the Fremantle Diabetes Study

  • Timothy M.E Davis

      Affiliations

    • University of Western Australia, Department of Medicine, Fremantle Hospital, P.O. Box 480, Fremantle, W.A. 6959, Australia
    • Corresponding Author InformationCorresponding author. Tel.: +1-618-94313229; fax: +1-618-94312977
    • ,
  • Matthew Knuiman

      Affiliations

    • University of Western Australia, Department of Public Health, Nedlands, Perth, W.A. 6907, Australia
    • ,
  • Peter Kendall

      Affiliations

    • Department of Respiratory Medicine, Fremantle Hospital, P.O. Box 480, Fremantle, W.A. 6959, Australia
    • ,
  • Hien Vu

      Affiliations

    • University of Western Australia, Department of Public Health, Nedlands, Perth, W.A. 6907, Australia
    • ,
  • Wendy A Davis

      Affiliations

    • University of Western Australia, Department of Medicine, Fremantle Hospital, P.O. Box 480, Fremantle, W.A. 6959, Australia

Received 19 January 2000 ,Revised 30 March 2000 ,Accepted 2 May 2000.

References 

  1. Schuyler MR, Niewoehner DE, Inkley SR, Kohn R. Abnormal lung elasticity in juvenile diabetes mellitus. Am. Rev. Respir. Dis. 1976;113:37–41
  2. Lange P, Groth S, Kastrup J, et al.  Diabetes mellitus, plasma glucose and lung function in a cross-sectional population study. Eur. Respir. J. 1989;2:14–19
  3. Barrett-Connor E, Frette C. NIDDM, impaired glucose tolerance, and pulmonary function in older adults. Diabetes. Care. 1996;19:1441–1444
  4. Feldman EL, Stevens MJ, Thomas PK, Brown MB, Canal N, Greene DA. A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy. Diabetes Care. 1994;17:1281–1289
  5. American Thoracic Society . Standardization of spirometry. 1994 update. Am. J. Respir. Crit. Care Med. 1995;152:1107–1136
  6. Milne JS, Williamson J. Respiratory function tests in older people. Clin. Sci. 1972;42:371–381
  7. Oscherwitz M, Edlavitch SA, Baker TR, et al.  Differences in pulmonary functions in various racial groups. Am. J. Epidemiol. 1972;96:319–327
  8. Woolcock AJ, Coleman MH, Blackburn CRB. Factors affecting normal values for ventilatory lung function. Am. Rev. Respir. Dis. 1972;106:692–709
  9. American Thoracic Society . Lung function testing: selection of reference values and interpretative strategies. Am. Rev. Respir. Dis. 1991;144:1202–1218
  10. Schlesinger ZV, Goldbourt U, Medlaie JH, Neufeld N, Riss E, Oron D. Ischemic heart disease and pulmonary ventilatory function. Isr. J. Med. Sci. 1975;11:308–313
  11. Enright PL, Kronmal RA, Smith VE, Gardin JM, Schenker MB, Manolio TA. Reduced vital capacity in elderly persons with hypertension, coronary heart disease, or left ventricular hypertrophy. The Cardiovascular Health Study. Chest. 1995;107:6–7
  12. Cook DG, Shaper AG. Breathlessness, lung function and the risk of heart attack. Eur. Heart J. 1988;9:1215–1222
  13. Lazarus R, Gore CJ, Booth M, Owen N. Effects of body composition and fat distribution on ventilatory function in adults. Am. J. Clin. Nutr. 1998;68:35–41
  14. Jenkins SC, Moxham J. The effects of mild obesity on lung function. Respir. Med. 1991;85:309–311
  15. Cavan DA, Parkes A, O'Donnell MJ, Freeman W, Cayton RM. Lung function and diabetes. Respir. Med. 1991;85:257–258
  16. Kannel WB, D'Agostino RB, Silbershatz H. Use of vital capacity for cardiac failure risk estimation in persons with coronary disease and left ventricular hypertrophy. Am. J. Cardiol. 1996;77:1155–1158

PII: S0168-8227(00)00166-2

Diabetes Research and Clinical Practice
Volume 50, Issue 2 , Pages 153-159 , 1 October 2000

Article Tools